LOS ANGELES (KABC) -- Long before vaccines, the focus was on a handful of COVID-19 treatments that provided glimmers of hope. The first to emerge was convalescent plasma. It offered a way for ...
Researchers from the Johns Hopkins Bloomberg School of Public Health supported the first blood center in the U.S. to be granted full FDA approval to provide convalescent plasma to immunocompromised ...
With rising rent, utilities and the cost of groceries, a growing number of people are selling their blood plasma to make extra money. It's a multi-billion dollar industry. The rising cost of living ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results